Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rifampin.

M Schonell, E Dorken, S Grzybowski

    Canadian Medical Association Journal
    |April 8, 1972
    PubMed
    Summary
    This summary is machine-generated.

    Rifampin, combined with other drugs like ethambutol, shows high effectiveness in treating drug-resistant tuberculosis, achieving nearly 100% sputum conversion. This combination may reduce treatment duration and replace older therapies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Desmoid tumour around the DIEP anastomosis - a rare complication after breast reconstruction].

    Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V...·2014
    Same author

    Pneumoconioses and their prevention.

    Canadian family physician Medecin de famille canadien·2011
    Same author

    Obstetric service in rural areas.

    Canadian family physician Medecin de famille canadien·2011
    Same author

    Rifampin.

    Canadian Medical Association journal·2010
    Same author

    Immunization in tuberculosis.

    Canadian Medical Association journal·2010
    Same author

    [A microangiography technique to quantify fasciocutaneous blood vessels in small laboratory animals].

    Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V...·2006
    Same journal

    Tularaemia; a problem in diagnosis.

    Canadian Medical Association journal·2010
    Same journal

    CONTROL of cancer.

    Canadian Medical Association journal·2010
    Same journal

    Bilateral diphtheritic external otitis treated with sulfathiazole.

    Canadian Medical Association journal·2010
    Same journal

    Hypoplastic anaemia treated with transfusions and folic acid fraction.

    Canadian Medical Association journal·2010
    Same journal

    Lauron in rheumatoid arthritis; a further report.

    Canadian Medical Association journal·2010
    Same journal

    HOW the socialist looks at national health service in England.

    Canadian Medical Association journal·2010
    See all related articles

    Area of Science:

    • Pharmacology
    • Infectious Diseases
    • Microbiology

    Background:

    • Tuberculosis (TB) treatment relies on effective drug regimens.
    • Drug-resistant TB poses a significant global health challenge.
    • Rifampin is a cornerstone antitubercular agent.

    Purpose of the Study:

    • To evaluate the efficacy of rifampin in combination therapy for drug-resistant tuberculosis.
    • To assess the potential of rifampin and ethambutol as a powerful treatment combination.
    • To explore the implications of rifampin in first-line TB treatment protocols.

    Main Methods:

    • Clinical evaluation of combination drug therapies for TB.
    • Assessment of sputum conversion rates in patients.
    • Monitoring for adverse effects and drug resistance development.

    Related Experiment Videos

    Main Results:

    • Rifampin combined with ethambutol achieves nearly 100% sputum conversion.
    • Rifampin and ethambutol are proposed to replace streptomycin and PAS in first-line treatment.
    • Optimal first-line treatment including rifampin, isoniazid (INH), and ethambutol shows high success probability and potential for reduced duration.

    Conclusions:

    • Rifampin-based combination therapy is highly effective for drug-resistant TB.
    • Rifampin and ethambutol represent a potent and promising treatment combination.
    • Close patient supervision is crucial to manage side effects and prevent rifampin resistance.